Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
作者:
主题词
动物(Animals);抗代谢药, 抗肿瘤(Antimetabolites, Antineoplastic);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);碳硫裂合酶类(Carbon-Sulfur Lyases);脱氧胞苷(Deoxycytidine);用药计划表(Drug Administration Schedule);抗药性, 肿瘤(Drug Resistance, Neoplasm);基因表达(Gene Expression);人类(Humans);注射, 腹腔内(Injections, Intraperitoneal);男(雄)性(Male);甲硫氨酸(Methionine);小鼠(Mice);小鼠, 裸(Mice, Nude);分子靶向治疗(Molecular Targeted Therapy);胰腺肿瘤(Pancreatic Neoplasms);重组蛋白质类(Recombinant Proteins);肿瘤负荷(Tumor Burden);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1080/15384101.2018.1445907
PMID
29623758
发布时间
2024-03-28
- 浏览10

Cell cycle (Georgetown, Tex.)
868-873页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文